Compounds > clopidogrel

clopidogrel and Diabetic Glomerulosclerosis

clopidogrel has been researched along with Diabetic Glomerulosclerosis in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (33.33)29.6817
2010's4 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Daimon, S1
Halicioglu, S; Kargı, E; Ozyalvacli, ME; Uyeturk, U1
Berger, PB; Bhatt, DL; Dasgupta, A; Dimas, AP; Fox, KA; Haffner, SM; Mak, KH; Montalescot, G; Shao, M; Steg, PG; Steinhubl, SR; Topol, EJ; Weber, MA1
Alfonso, F; Angiolillo, DJ; Bass, TA; Bernardo, E; Capodanno, D; Fernandez-Ortiz, A; Ferreiro, JL; Jimenez-Quevedo, P; Macaya, C; Sabaté, M; Ueno, M; Vivas, D1
Chinnakotla, S; Fidler, ME; Hammeke, MD; Leone, JP; Tarantolo, S1

Trials

1 trial(s) available for clopidogrel and Diabetic Glomerulosclerosis

ArticleYear
Clinical outcomes of patients with diabetic nephropathy randomized to clopidogrel plus aspirin versus aspirin alone (a post hoc analysis of the clopidogrel for high atherothrombotic risk and ischemic stabilization, management, and avoidance [CHARISMA] tri
    The American journal of cardiology, 2009, May-15, Volume: 103, Issue:10

    Topics: Aspirin; Cardiovascular Diseases; Chi-Square Distribution; Clopidogrel; Diabetic Nephropathies; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Proportional Hazards Models; Survival Analysis; Ticlopidine; Treatment Outcome

2009

Other Studies

5 other study(ies) available for clopidogrel and Diabetic Glomerulosclerosis

ArticleYear
Recommendations on the Clinical Use of Compound Danshen Dripping Pills.
    Chinese medical journal, 2017, Apr-20, Volume: 130, Issue:8

    Topics: Angina Pectoris; Aspirin; Camphanes; Clopidogrel; Coronary Disease; Diabetes Mellitus; Diabetic Nephropathies; Diabetic Retinopathy; Drugs, Chinese Herbal; Humans; Meta-Analysis as Topic; Panax notoginseng; Salvia miltiorrhiza; Ticlopidine

2017
Adverse Effect of Antithrombotic Medications on Bleeding Events and Comparison of Antithrombotic Agents in Hemodialysis Patients.
    Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy, 2019, Volume: 23, Issue:1

    Topics: Aged; Aspirin; Cilostazol; Clopidogrel; Diabetic Nephropathies; Drug Monitoring; Female; Fibrinolytic Agents; Hemorrhage; Hospitalization; Humans; Japan; Male; Middle Aged; Renal Dialysis; Risk Assessment; Withholding Treatment

2019
Spontaneous renal parenchymal hematoma associated with clopidogrel in a patient with diabetic nephropathy.
    The Annals of pharmacotherapy, 2015, Volume: 49, Issue:2

    Topics: Aged; Clopidogrel; Diabetic Nephropathies; Hematoma; Humans; Kidney Diseases; Male; Platelet Aggregation Inhibitors; Renal Dialysis; Retroperitoneal Space; Ticlopidine

2015
Impact of chronic kidney disease on platelet function profiles in diabetes mellitus patients with coronary artery disease taking dual antiplatelet therapy.
    Journal of the American College of Cardiology, 2010, Mar-16, Volume: 55, Issue:11

    Topics: Aged; Aspirin; Blood Platelets; Clopidogrel; Coronary Artery Disease; Cross-Sectional Studies; Diabetes Mellitus; Diabetic Angiopathies; Diabetic Nephropathies; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Risk Factors; Ticlopidine; Treatment Outcome

2010
Clopidogrel-associated thrombotic thrombocytopenic purpura/hemolytic uremic syndrome in a kidney/pancreas transplant recipient.
    Transplantation, 2000, Aug-15, Volume: 70, Issue:3

    Topics: Adult; Clopidogrel; Coronary Disease; Cyclosporine; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Hemolytic-Uremic Syndrome; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Pancreas Transplantation; Plasmapheresis; Platelet Aggregation Inhibitors; Purpura, Thrombotic Thrombocytopenic; Ticlopidine

2000